Therapy of cutaneous metastases of malignent melanoma;Therapie von hautmetastasen beim malignen melanom

Hautarzt

Volumn 57, Issue 12, 2006, Pages 1143-1153

  Rehberger, P ^a   Eppinger, S ^a   Stein, A ^a   Schmitt, J ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Cutaneous metastases; ILP; Malignant melanoma; Radiation; Surgery

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INTERLEUKIN 2; MELPHALAN; THYMOPENTIN;

ADVANCED CANCER; BONE MARROW SUPPRESSION; CANCER INCIDENCE; CARBON DIOXIDE LASER; CRYOTHERAPY; HUMAN; LIMB PERFUSION; LOW LEVEL LASER THERAPY; MELANOMA; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PROGNOSIS; QUALITY OF LIFE; REVIEW; SKIN METASTASIS; VISCERAL METASTASIS;

ANTINEOPLASTIC AGENTS, ALKYLATING; HUMANS; LASER SURGERY; MELANOMA; MELPHALAN; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RADIOTHERAPY; SKIN NEOPLASMS;

EID: 33845430046     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-006-1253-1     Document Type: Review

References (46)

1. Balch CM, Soong SJ, Gershenwald JE et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19: 3622-3634
2. Bong AB, Bonnekoh B, Franke I et al. (2002) Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatol 205: 135-138
3. Burke K, David M, Junge K, Sindermann H (1994) Overview on the clinical development of miltefosine solution (Miltex®) for the treatment of cutaneous breast cancer. Drugs today 30 [Suppl B]: 59-72
4. Burris HA, Vogel CL, Castro D et al. (1998) Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg 118: 496-503
5. Cascinelli N, Clemente C, Bufalino R et al. (1993) Perinodular injection of thymopentin (TP 5) in cutaneous and subcutaneous metastases of melanoma. Mel Res 3: 471-476
6. Clark J, Grabs AJ, Parsons PG et al. (1994) Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma. Melanoma Res 4: 365-370
7. Creech O Jr, Krementz E (1966) Techniques of regional perfusion. Surgery 60: 938-947
8. Fenig E, Eidelevich E, Njuguna E et al. (1999) Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol 22: 184-186
9. Fierlbeck G, d'Hoedt B, Stroebel W et al. (1992) Intraläsionale Therapie von Melanommetastasen mit rekombinantem Interferon-β. Hautarzt 43: 16-21
10. Fraker DL (1999) Hyperthermic regional perfusion for melanoma and sarcoma of the lims. Curr Probl Surg 36: 841-907
11. Garbe C, Hauschild A, Volkenandt M et al. (2005) Deutsche Leitlinie: Malignes Melanom, In: Garbe C (Hrsg) Interdisziplinäre Leitlinien zur Diagnostik und Behandlung von Hauttumoren. Thieme, Stuttgart, S 23-55
12. Gibson SC, Byrne DS, McKay AJ (2004) Ten-year experience of carbon dioxide laser ablation as treatment for cutaneous recurrence of malignant melanoma. Br J Surg 91(7): 893-895
13. Grünhagen DJ, de Wilt JH, van Geel AN, Eggermont AM (2006) Isolated limb perfusion for melanoma patients - a review of its indications and the role of tumor necrosis factor-α. Eur J Surg Oncol 32: 371-380
14. Hoeller C, Jansen B, Heere-Ress E et al. (2001) Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastases. J Invest Dermatol 117: 371-374
15. Illig L, Paul E (1976) Unspezifische epifokale Immuntherapie des malignen Melanoms der Haut mit DNCB nach Malek-Mansour. Hautarzt 27: 579-587
16. Kaplan I, Ger R, Sharon U (1973) The carbon dioxide laser in plastic surgery. Br J Plast Surg 26: 359-362
17. Karrer S, Szeimies RM, Hohenleutner U, Landthaler M (2001) Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2(4): 229-237
18. Katalinic A, Kunze U, Schafer T (2003) Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 149(6): 1200-1206
19. Kozlov AP, Moskalik KG (1980) Pulsed laser radiation therapy of skin tumors. Cancer 46: 2172-2178
20. Lindner P, Doubrovsky A, Kam PC, Thompson JF (2002) Prognostic factors after isolated limb perfusion with cytotoxic agents for melanoma. Ann Surg Oncol 9: 127-136
21. Lingam MK, McKay AJ (1995) Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases from malignant melanoma. Br J Surg 82(10): 1346-1348
22. Loquai C, Nashan D, Metze D et al. (2004) Imiquimod, pegyliertes Interferon-α-2b und Interleukin-2 in der Behandlung kutaner Melanommetastasen. Hautarzt 55:176-181
23. Malek-Mansour S (1973) Remission of melanoma with DNCB treatment. Lancet 2: 503-504
24. Meier F, Will S, Ellwanger U et al. (2002) Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 147(1): 62-70
25. Oratz R, Hauschild A, Sebastian G et al. (2003) Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma. Mel Res 13(1): 59-66
26. Overgaard J, Gonzalez Gonzales D, Hulshof MC et al. (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European society for hyperthermic oncology. Lancet 345: 540-543
27. Radny P, Caroli UM, Bauer J et al. (2003) Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. Br J Canc 89: 1620-1626
28. Ragnarsson-Olding B, Djureen-Martensson E, Mansson-Brahme E, Hansson (2005) Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex). Acta Oncol 44(7): 773-777
29. Rajpar SF, Marsden JR (2006) Imiquimod in the treatment of lentigo maligna. Br J Dermatol 155(4): 653-656
30. Rapprich H, Hagedorn M (2006) Intraläsionäre Behandlung mit Interferon-β beim metastasierten Melanom. JDDG 4: 743-746
31. Ridolfi L, Ridolfi R, Ascari-Raccagni A et al. (2001) Intralesional granulocyte-monocyte colony-stimulating factor followed by subcutaneous interleukin-2 in metastatic melanoma: a pilot study in elderly patients. J Eur Acad Dermatol Venereol 15: 218-223
32. Rosenberg SA, Yang JC, White DE et al. (1998) Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2. Ann Surg 228: 307-319
33. Rossi CR, Foletto M, Mocellin S et al. (2004) Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-α and melphalan fur bulky in-transit melanoma metastases. Ann Surg Oncol 11(2): 173-177
34. Sauze WT (1991) Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Bil Phys 20: 419-432
35. Schraffordt Koops H, Vaglini M, Suciv S et al.(1998) Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. J Clin Oncol 16: 2906-2912
36. Sebastian G, Stein A (2006) Das maligne Melanom der Haut. Uni-Med Science, Bremen, S 99
37. Stanley MA (2002) Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 27: 571-577
38. Stevens G, McKay MJ (2006) Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. Lancet Oncol 7(7): 575-583
39. Strobbe LJ, Hart AA, Rümke P et al. (1997) Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma. Mel Res 7: 507-512
40. Strobbe LJ, Nieweg OE, Kroon BB (1997) Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations. Eur J Surg Oncol 23(5): 435-438
41. Thompson JF, Gianoutsos MP (1992) Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs. World J Surg 16: 227-233
42. Thompson JF, Scolyer RA, Kefford RF (2005) Cutaneous Melanoma. Lancet 365: 687-701
43. Vrouenraets BC, Nieweg OE, Kroon BB (1996) Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg 83: 1319-1328
44. Wieberdink J, Benck Huysen C, Braat RP et al. (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 18: 905-910
45. Wolf IH, Smolle J, Binder B et al. (2003) Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 139: 273-276
46. Wolf P, Rieger E, Kerl H (1993) Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol 28(1): 17-21. Erratum in: J Am Acad Dermatol 29(1): 41